Davina Pharmacy Limited - Period Ending 2022-07-31

Davina Pharmacy Limited - Period Ending 2022-07-31


Davina Pharmacy Limited 04990110 false 2021-08-01 2022-07-31 2022-07-31 The principal activity of the company is that of pharmacutical supplies. Digita Accounts Production Advanced 6.30.9574.0 true 04990110 2021-08-01 2022-07-31 04990110 2022-07-31 04990110 core:CurrentFinancialInstruments 2022-07-31 04990110 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 04990110 core:Non-currentFinancialInstruments 2022-07-31 04990110 core:Non-currentFinancialInstruments core:AfterOneYear 2022-07-31 04990110 core:Goodwill 2022-07-31 04990110 core:FurnitureFittingsToolsEquipment 2022-07-31 04990110 core:LandBuildings 2022-07-31 04990110 core:OtherPropertyPlantEquipment 2022-07-31 04990110 bus:SmallEntities 2021-08-01 2022-07-31 04990110 bus:AuditExemptWithAccountantsReport 2021-08-01 2022-07-31 04990110 bus:FullAccounts 2021-08-01 2022-07-31 04990110 bus:SmallCompaniesRegimeForAccounts 2021-08-01 2022-07-31 04990110 bus:RegisteredOffice 2021-08-01 2022-07-31 04990110 bus:Director1 2021-08-01 2022-07-31 04990110 bus:Director2 2021-08-01 2022-07-31 04990110 bus:Director3 2021-08-01 2022-07-31 04990110 bus:PrivateLimitedCompanyLtd 2021-08-01 2022-07-31 04990110 core:Goodwill 2021-08-01 2022-07-31 04990110 core:FurnitureFittings 2021-08-01 2022-07-31 04990110 core:FurnitureFittingsToolsEquipment 2021-08-01 2022-07-31 04990110 core:LandBuildings 2021-08-01 2022-07-31 04990110 core:OfficeEquipment 2021-08-01 2022-07-31 04990110 core:OtherPropertyPlantEquipment 2021-08-01 2022-07-31 04990110 core:PlantMachinery 2021-08-01 2022-07-31 04990110 countries:UnitedKingdom 2021-08-01 2022-07-31 04990110 2021-07-31 04990110 core:Goodwill 2021-07-31 04990110 core:FurnitureFittingsToolsEquipment 2021-07-31 04990110 core:LandBuildings 2021-07-31 04990110 core:OtherPropertyPlantEquipment 2021-07-31 04990110 2020-08-01 2021-07-31 04990110 2021-07-31 04990110 core:CurrentFinancialInstruments 2021-07-31 04990110 core:CurrentFinancialInstruments core:WithinOneYear 2021-07-31 04990110 core:Non-currentFinancialInstruments 2021-07-31 04990110 core:Non-currentFinancialInstruments core:AfterOneYear 2021-07-31 04990110 core:Goodwill 2021-07-31 04990110 core:FurnitureFittingsToolsEquipment 2021-07-31 04990110 core:LandBuildings 2021-07-31 04990110 core:OtherPropertyPlantEquipment 2021-07-31 iso4217:GBP xbrli:pure

Registration number: 04990110

Davina Pharmacy Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 July 2022

 

Davina Pharmacy Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Davina Pharmacy Limited

Company Information

Directors

Mr Imraan Khan

Mr David Ashton

Mr Philip Ashton

Registered office

155 Elliott Street
Tyldesley
Manchester
M29 8FL

Accountants

EKWilliams Accountants Limited
1 Pavilion Square
Westhoughton
Bolton
BL5 3AJ

 

Davina Pharmacy Limited

(Registration number: 04990110)
Balance Sheet as at 31 July 2022

Note

2022
£

2021
£

Fixed assets

 

Intangible assets

4

-

45,334

Tangible assets

5

26,702

34,114

 

26,702

79,448

Current assets

 

Stocks

6

38,396

22,688

Debtors

7

755,459

874,200

Cash at bank and in hand

 

96,280

128,927

 

890,135

1,025,815

Creditors: Amounts falling due within one year

8

(250,475)

(490,378)

Net current assets

 

639,660

535,437

Total assets less current liabilities

 

666,362

614,885

Creditors: Amounts falling due after more than one year

8

(16,052)

(28,429)

Provisions for liabilities

(1,679)

(2,239)

Net assets

 

648,631

584,217

Capital and reserves

 

Called up share capital

100

100

Retained earnings

648,531

584,117

Shareholders' funds

 

648,631

584,217

For the financial year ending 31 July 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Davina Pharmacy Limited

(Registration number: 04990110)
Balance Sheet as at 31 July 2022

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 27 April 2023 and signed on its behalf by:
 

.........................................
Mr Imraan Khan
Director

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
155 Elliott Street
Tyldesley
Manchester
M29 8FL
England

These financial statements were authorised for issue by the Board on 27 April 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office Equipment

25% Reducing Balance

Leasehold Property

25% Reducing Balance

Plant & Machinery

25% Reducing Balance

Fixtures & Fittings

25% Reducing Balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

Over 10 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 11 (2021 - 11).

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 August 2021

400,000

400,000

At 31 July 2022

400,000

400,000

Amortisation

At 1 August 2021

354,666

354,666

Amortisation charge

45,334

45,334

At 31 July 2022

400,000

400,000

Carrying amount

At 31 July 2022

-

-

At 31 July 2021

45,334

45,334

5

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 August 2021

133,100

146,919

4,717

284,736

At 31 July 2022

133,100

146,919

4,717

284,736

Depreciation

At 1 August 2021

110,769

135,600

4,253

250,622

Charge for the year

4,466

2,830

116

7,412

At 31 July 2022

115,235

138,430

4,369

258,034

Carrying amount

At 31 July 2022

17,865

8,489

348

26,702

At 31 July 2021

22,331

11,319

464

34,114

Included within the net book value of land and buildings above is £17,865 (2021 - £22,331) in respect of long leasehold land and buildings.
 

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

6

Stocks

2022
£

2021
£

Finished goods and goods for resale

38,396

22,688

7

Debtors

Current

Note

2022
£

2021
£

Trade debtors

 

114,365

231,177

Amounts owed by related parties

478,972

399,814

Other debtors

 

162,122

243,209

   

755,459

874,200

 

Davina Pharmacy Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2022

8

Creditors

Creditors: amounts falling due within one year

Note

2022
£

2021
£

Due within one year

 

Loans and borrowings

9

12,078

4,792

Trade creditors

 

165,984

206,482

Taxation and social security

 

23,099

32,724

Accruals and deferred income

 

2,000

2,500

Other creditors

 

47,314

243,880

 

250,475

490,378

Creditors: amounts falling due after more than one year

Note

2022
£

2021
£

Due after one year

 

Loans and borrowings

9

16,052

28,429

9

Loans and borrowings

2022
£

2021
£

Non-current loans and borrowings

Bank borrowings

16,052

28,429

2022
£

2021
£

Current loans and borrowings

Bank borrowings

12,078

4,792